INTRODUCTION
Bacterial kidney disease is a chronic, systemic, granulomatous, and often fatal disease prevalent among juvenile and adult salmonids (Fryer & Sanders 1981) . Bacterial kidney disease is one of the most difficult bacterial diseases to control in salmonid aquaculture facilities due in part to 2 unusual pathogenic mechanisms of the causative agent, Renibacterium salmoninarum (Elliott et al. 1989) . First, R. salmoninarum can 'E-mail: wiensg@ohsu.edu "Present address: Department of Veterinary Medicine, National Chung Hsing University, 250 Kuo Kuang Road, Taichung, Taiwan 40227, ROC be vertically transmitted from female fish to offspring via intracellular infection of the egg (Evelyn et al. 1984 (Evelyn et al. , 1986 . Second, the bacterium can reside intracellularly within salmonid phagocytes and other host cells which may hinder immune clearance (Young & Chapman 1978 , Bruno & Munro 1986 , Gutenberger et al. 1997 , McIntosh et al. 1997 . Little is known about the molecular mechanisms of pathogenesis or the host immune response (Evenden et al. 1993) , however, this knowledge is crucial for the development of more efficacious therapeutics and vaccines. The best characterized virulence factor of Renibacterium salmoninarum is a 57-58 kDa protein (p57). This protein is exposed on the bacterial cell surface of most strains and is also abundantly secreted by the bacteria during growth in culture media or infection of MATERIALS AND METHODS fish (Getchell et al. 1985 , Turaga et al. 1987b subunit structure of p57 was also examined with fast Kaattari 1989, Rockey et al. 1991a , Bandin et al. 1992 .
pressure liquid chromatography (FPLC) and ELISA Cell-assoc~ated p57 has been reported to be necessary and we found that secreted p57 was present as a for virulence as spontaneous mutants of R. salmoni-monomer in culture supernatant as well as infected narum lacking cell-associated p57 were less virulent fish tissue. The monomer, purified from bacterial culupon intraperitoneal challenge (Bruno 1988 (Bruno , 1990 . ture supernatant, was sufficient for agglutination of However, whether these mutants completely lack ex-rabbit erythrocytes and fish leucocytes in vitro. pression of p57 has been questioned (Grayson et al. 1995) .
The function of secreted p57 in pathogenesis is unclear and sequence comparison with other proteins has so far been uninformative. P57 is a glycine rich, Animals. Rainbow trout Oncorhynchus mykiss were 557 amino acid protein containing 2 copies of a n 81 held in 12°C well water at the Oregon State University residue direct repeat, which are 60% homologous, and Salmon Disease Laboratory and were fed Oregon 5 copies of a second 25 residue imperfect repeat Moist Pellets (Bioproducts, Warrington, OR). Samples (Chien et al. 1992) . One function of p57 may be to of infected ludney tissue were obtained from spawning mediate adherence of the bacteria to host tissues. P57 spring chinook salmon (0. tshawytscha) at Marion has been reported to form a fimbrial structure on the Forks Hatchery, OR, and Carson Hatchery, WA, and bacterial cell surface and has a number of other char-homogenized as previously described (Rockey et al. acteristics of bacterial adhesins including haemagglu-1991a) . tinating activity, a n acidic isoelectric point, and hydro-Purification of MAbs. Cell-free ascites fluid from phobic amino acid composition (Jones & Isaacson 1983, group I MAbs (4Cl1, 4H8, and 4D3) , group I1 MAbs Daly & Stevenson 1990 , Dubreuil et al. 1990a (2G5 and 3H1) and group 111 MAbs (1Al and 4D10) Kaattari 1991). In vitro, the secreted form of p57 has were collected and purified by protein A chromatograimmunomodulatory effects as it is able to bind and phy as described previously (Wiens & Kaattari 1991) . agglutinate salmonid leucocytes and suppress anti-Protein content was determined by the method of body production to the unrelated antigens, trinitro- Lowry et al. (1951) . phenylated lipopolysaccharide and human gamma-Extracellular protein (ECP) concentration. Renibacglobulin (Turaga et al. 1987a , Rockey et al. 1991b , and terium salmoninarum ATCC 33209 extracellular pro-Wiens & Kaattari 1991 , Fredriksen et al. 1997 . In addi-tein was harvested from medium and concentrated as tion, injection of coho salmon eggs with p57 has been described previously (Wiens & Kaattari 1991) . The prereported to result in long term irnmunosuppression dominant component of ECP prepared in this manner (Brown et al. 1996) .
is p57 with associated proteolytic degradation frag-We have previously identified functional domains of ments (Rockey et al. 1991b , Wiens & Kaattari 1991 . p57 using a panel of 8 anti-p57 monoclonal antibodies Total protein was assessed by the method of Lowry et (MAbs) (Wiens & Kaattari 1991) . Three of the MAbs al. (1951) using bovine serum albumin (BSA, Sigma, St. (4D3, 4H8, and 4Cl l ) inhibit haemagglutinating Louis, MO) as a standard. The ECP was filter-sterilized activity while 2 of these MAbs (4H8 and 4 C l l ) inhibit (0.45 pm) and stored at -70°C or kept at 4°C for immethe leucoagglutinating activity of p57. The 3 agglutina-diate use. tion inhibiting MAbs, referred to as group I MAbs, ELISA. A capture ELISA was performed as described putativly recognize epitopes located on the amino-previously (Wiens & Kaattari 1989) . Briefly, in this terminal third of p57, as determined by amino acid assay 5 pg ml-' MAbs 4D3. 4H8, 4Cl1, or polyclonal sequenclng of p57 and immunoblotting of partial p57 rabbit anti-ECP were separately coated onto the plate, proteolytic digests. Group I1 MAbs (3H1 and 2G5) non-specific sites blocked with 1 % BSA -0.1 % recognize epitopes located in the central region of p57, Tween-Tris buffered saline (TTBS; 50 mM Tris, 1 mM while group I11 MAbs (1Al,4D10 and 2G9A) recognize EDTA, 8.7% NaCl, pH 8.0), and then 5 pg ml-' ECP in epitopes present in the carboxy-terminal third of p57 0.1 % TTBS was added. After washing the wells, 5 pg that are not exposed when intact p57 is attached to the ml-' of a biotinylated detection MAb was added as a Renibactenum salmoninarum cell surface. probe to screen for available epitopes on p57. Strepta-In this study, the functional domains of p57 were fur-vidin-horseradish peroxidase (Sigma) was then added ther defined. The group I MAbs recognized separate to determine the amount of bound biotinylated antinon-overlapping epitopes in an enzyme linked im-body. To measure non-specific binding, biotinylated munosorbent assay (ELISA) and these epitopes were MOPC-21, a l g G , ,~ MAb of unknown specificity, was localized on the amino-terminal portion of p57 by used as a negative control (Sigma). Formalin-fixed irnmunoblotting of recombinant fragments of p57. The
Renibacfenum salmoninarum cells were used as a positive control to show that aggregates of p57 could be detected by the ELISA. R. salmoninarum cells were fixed for 12 h with 0.3 % formalin, washed 3x in phosphate buffered saline (10 mM, PBS, pH 7.21, and resuspended at a concentration of 50 1-19 wet wt ml-' of 1 % BSA in 0.1 % TTBS. Purification of p57. FPLC was used to purify p57 from ECP. Prior to FPLC, ECP was dialyzed in 50 mM phosphate buffer (pH 7.2) and filtered through a 0.2 pm low protein binding filter (Acrodisc 13, Gelman Sciences, Ann Arbor, MI). Approximately 3.9 mg of protein was loaded onto a HR 5/5 Mono Q anion exchange column and eluted with a biphasic salt gradient of 0 to 0.6 M NaC1, followed by 0.G to 1.0 M NaCl in 50 mM phosphate buffer (pH 7.2). One milliliter fractions from the anion exchange column were stored at -70°C until analyses were performed. A biphasic salt gradient eluted approximately 70% of the total protein in fractions 1 to 30 (see Fig. 3A ).
To determine the native molecular weight of p57, fraction 6 (75 pg total protein) from the anion exchange column was separated on a HR 10/30 Superose 12 FPLC gel filtration column (10 X 30 cm, Pharmacia) using a buffer of 50 mM NaCl, 50 mM phosphate (pH 7.2) and 1 mM phenylmethylsulfonyl fluoride protease inhibitor (PMSF). The peak absorbing fraction (15) from the gel filtration column was concentrated 12-fold by ultrafiltration using a Centricon-3 (3000 MW cutoff, Amicon Division, Grace and Co., CT).
Protease assay. The protease assay adapted from Sarath et al. (1989) used filter sterilized substrate solution of 2 O/o azoalbumin (Sigma) in a 0.1 % sodium dodecyl sulfate, 10 mM phosphate, 7.5% NaCl buffer (pH 7.2). Protease activity was determined by mixing 30 p1 of each column fraction with 50 p1 of substrate at an incubation temperature of 37°C for 15 h. Intact substrate was precipitated with 200 p1 of 10% tnchloroacetic acid for 15 min at room temperature. Samples were microfuged for 5 min, and 100 p1 of supernatant was transferred to ELISA wells to which 100 p1 1.0 M NaOH was added. The A,,, (absorbance at 450 nm) was determined using an EIA autoreader (Biotek Instruments, Burlington, VT). Units of activity were calculated from a log-log plot using trypsin (#T2271, Bovine Pancreas, Sigma) as a standard.
Leucoagglutination and haemagglutination assays. Rainbow trout leucocytes and rabbit erythrocytes were prepared as previously described (Wiens & Kaattari 1991) , except that leucocytes were resuspended to a final concentration of 2 % autologous plasma (DeKoning & Kaattari 1991) instead of 10 % fetal bovine serum. Agglutination reactions worked equally well in either serum source. A total of 1.0 X 106 leucocytes well-' or 1.5 X 106 erythrocytes well-' were mixed with 50 p1 of column fraction or 2-fold dilutions of each fraction.
Agglutination was assessed after 24 h by microscopic examination.
Construction and expression of recombinant, truncated p57 fragments. A 636 nt EcoRI to XhoI fragment encoding amino acids 32 to 243 of p57 was subcloned into PET-22b(+) (Novagen, Madison, WI). A second construct containing the carboxy-terminal amino acids 242 to 557 was generated by PCR amplification with the reverse primer 5'-CGCGCTCGAGGTTAAAGGT-AATATCTAT and a forward primer 5'-CCGACAGC-AACTCTCGAGCCT. Hot start PCR amplification was carried out as recommended (Perkin Elmer, Norwalk, CT) using 5U of Ultma polymerase and 750 ng of target DNA. Twenty an~plification cycles (94"C, 30 S; 55"C, 2 mini 72"C, 3 min) were followed by 10 min at 72°C. Following PCR, the product was purified and digested with XhoI and the 946 bp fragment subcloned into PET 22b(+) expression vector and confirmed by sequencing. Both constructs were expressed according to the protocol supplied with the pET22b(+) vector (Novagen). Briefly, the constructs were transformed into E. coli BL 21 and grown to an O.D. of 0.6 (600 nm). The expression of the His-tag fusion proteins was induced with 1 mM IPTG for 2 h. Bacterial cells were washed in 50 mM Tris, pH 8.0,2 mM EDTA, and stored as a pellet at -70°C. Thawed cells were resuspended 1:4 wt: v01 in 50 mM Tris, pH 8.0, 2 mM EDTA, and 40 1. 11 of this suspension was mixed with 10 p1 1 M DTT and 50 p1 2x SDS-PAGE sample buffer. Samples were boiled for 3 min, and sonicated for 2 s (Heat System Ultra Sonicator Inc.). Standard 10 or 12% SDS-PAGE and Western blotting were performed as previously described using the Mini-PROTEAN I1 system (Bio-Rad) (Wiens et al. 1990 ).
RESULTS

Epitope identification using group I MAbs
In order to characterize the functional domains of p57 we used an antigen capture ELISA to determine if the epitopes recognized by the group I antibodies are distinct. Results from these experiments indicated that each of the 3 MAbs recognized spatially distinct epitopes ( Fig. lA,B ,C). For example, when 4D3 was coated onto wells, both heterologous biotinylated antibodies 4H8 (4H8-B), 4 C l l -B as well as polyclonal rabbit antisera (RB-B) bound to p57, while the homologous antibody (4D3-B) and negative control MAb MOPC 21-B did not bind (Fig. 1A) . Analogous results were obtained using the 4H8 and 4 C l l MAbs (Fig. lB,C) . Some binding of 4Cll-B to p57 captured by 4 C l l was observed, but was apparently nonspecific in nature as the level was similar to that ob-served using the negative control antibody MOPC21-B. Equivalent activity of each biotinylated antibody was demonstrated by its binding to ECP coated wells ( Fig. ID) .
Expression of a recombinant p57
To independently localize the epitopes recognized by the group I MAbs, the amino-terminal portion of p57 and a carboxy-terminal portion of p57 were expressed in E. coli BL21 with a pel-B leader and Histag ( Fig. 2A) . The amino terminal fragment, designated p57.NH2, contained amino acids 32 to 243 and included amino acid repeat A l . The carboxy-terminal fragment of p57, designated p57.COOH, contained amino acids 242 to 557 including amino acid repeat A2 and repeats B1-5. Expression of p57.NH2 and p57.COOH in E. coli was induced with IPTG and detected by Coomassie Blue staining of SDS-PAGE gels (Fig. 2B ). MAb recognition of the recombinant proteins was assessed by immunoblotting. Group I MAb, 4H8, bound the amino-terminal fragment (Fig. 2B, lane 2) , but not the carboxy-terminal fragment (lane 3). MAbs 4C11 and 4D3 showed a similar binding pattern (data not shown). Lack of binding to the car-
Coated with 4 C l l 2.07 f i boxy-terminal fragment containing repeat A2 suggests that the group I antibodies do not recognize shared epitopes located on repeat A1 and A2. Conversely, group I1 (MAb 2G5) and group I11 (MAb 1Al) antibodies recognized epitopes on the carboxy-terminal fragment (Fig. 2B, lane 3) but not the amino-terminal fragment (lane 2). MAbs 3H1 and 4D10 showed a similar binding pattern (data not shown). The expression of p57.COOH produced several immunoreactive bands that presumably represent proteolytic degradation products consistent with the previously observed proteolysis of recombinant p57 expressed in E. coli (Grayson et al. 1995) .
Purification of p57 from culture supernatant and analysis of agglutinating activity
To determine the subunit structure of p57 we used chromatographic methods to purify p57 from ECP. First, ECP was separated on an anion exchange mono-Q column. The majority of protein was eluted in the first 5 fractions as determined by absorbance at 280 nm (Fig. 3A) . P57 was the major component eluting in fractions 5 through 14 as determined by total protein staining of transblotted proteins from SDS-PAGE gels (Fig. 3B) . The identity of p57 in these fractions was further confirmed by Western blotting using MAb 1Al ( Fig. 4B ) and MAb 4D3 (not shown). Column fractions were also tested for haemagglutinating activity, proteolytic activity, and immunoreactivity by ELISA. Fractions 4 through 15 possessed haemagglutinating activity correlating with the elution of p57 (Fig. 4A) . Proteolytic activity, detected by azoalbumin degradation, was also observed in ECP and a major peak of activity eluted in fraction 3 prior to fractions in which the majority of p57 was found (Fig. 4A ). In addition, minor amounts of proteolytic activity were observed in fractions 10 through 15. Proteolytic activity was undetectable in fraction 6 which was used for further molecular weight characterization.
To determine the native molecular weight of p57, 75 pg of fraction 6 from the anion exchange column was subjected to superose size exclusion chromatography. Dextran blue (30 pg) was included as an internal marker. Two peaks were detected by A280 absorbance, the first peak was dextran blue at 7.5 m1 and the second peak eluted at a peak of 14.3 m1 A Repeat Regions 
Fraction (ml)
Fraction 2 5 7 9 1 2 1 4 1 6 1 8 1 9 2 0 2 2 2 4 2 6 ' i The protein content of the eluent was detected photometrically at 280 nm with a UV monitor (solid line). A linear salt gradient of 0 to 600 mM was used to elute proteins from fraction 6 to 28 (dotted h e ) . A 600 to 1000 mM salt gradient was used from fraction 28 to 32. (B) Total protein stain of FPLC anion exchange column fractions 2 through 26. A total of 2.5 p1 of each fraction was electrophoresed through a 10% SDS polyacrylamide gel and electroblotted onto nitrocellulose and total protein detected with a collodial gold stain. The results are representative of 2 experiments (Fig. 5A) . The second peak contained p57 as determined by a highly sensitive ELISA, and the majority of immunoreactivity eluted in fractions 14 through 17. Estimation of relative n~olecular weight of p57 using a panel of known proteins indicated that p57 eluted as a monomer with a calculated relative migration of 46500 Da (Fig. 5B) , as opposed to a dimer or multiaggregated protein which should have eluted prior to fraction 13. Fraction 15 was further concentrated and subject to electrophoresis and immunoblotting (Fig. 6 ). P57 was purified to near homogeneity (Fig. 6 , lane 3) , excluding a small amount of p45, as compared to the starting material (Fig. 6, lane 1) . The minimum concentration required for agglutinating activity of rainbow trout leucocytes was decreased from 25 pg ml-' of the To investigate whether monomers of p57 were present in infected fish tissue, we performed capture ELISA analysis on kidney homogenates from naturally Fraction infected adult chinook salmon. Similar to the analysis B 2 S 7 9 12 14 16 18 19 20 22 24 26 shown in Fig. 1, p57 captured by MAb 4D3 was not recognized by the homologous biotinylated MAb 4D3 but was recognized by the heterologous MAb 4H8-B (Fig. 7) . Formalin-fixed bacteria were used as a positive control to demonstrate that the combination of MAb 4D3 and 4D3-B could detect aggregates of p57. It is unclear why MAb 4D3-B showed less binding to the formalin-fixed bacterial cells at concentrations equivalent to those used with MAb 4H8-B, but perhaps this was due to steric hindrance from the coating MAb 4D3 or destruction of epitopes by formalin. ously, we found that 3 MAbs, 4H8, 4 C l l and 4D3, inhibit haemagglutinating activity while 2 of these MAbs, 4H8 and 4Cl l also inhibit the leucoagglutinating activity of p57 (Wiens & Kaattari 1991) . To determine if these antibodies recognize the same or distinct epitopes on p57 we used a capture ELISA. In this Coated with MAb 4D3 Fig. 7 . ELISA epitope analysis of kidney tissue from 3 infected adult chinook salmon which were previously found to have antigen levels above 1 pg ml-' Plates were coated with 5 pg rnl-' 4D3, blocked with 1 % BSA-TTBS, and either 5 pg ml-' ECP, formalin-fixed Renibacterium sa1moninaru:n cells (50 pg ml-l), or a 1:100 dilution of kidney tissue homogenate added. ELISA plates were then probed with 5 pg ml-' detection MAbs 4D3-B, 4H8-B or MOPC21-B. After substrate was added, plates were incubated for 10 min before was measured. Error bars denote standard deviations of triplicate wells assay, MAb 4D3, 4Cl l and 4H8 each recognized a distinct epitope. The locations of the 4D3, 4H8 and 4 C l l epitopes were confirmed to lie between amino acids 32 to 243 on p57 as all 3 of the MAbs bound the recombinant, amino-terminal fragment, p57.NH2, but not to the carboxy-terminal fragment, p57.COOH, in a Western blot. These findings are consistent with our previous data showing that group I MAbs bind aminoterminal proteolytic fragments of p57 (Wiens & Kaattari 1991) . Also consistent with our previous epitope map, group I1 MAbs (2G5 and 3 H l ) and group 111 MAbs (1Al and 4D10) bound p57.COOH but not p57.NH2. The demonstration that the 3 group I MAbs recognized separate epitopes, and that these epitopes are separate from epitopes bound by the group I1 or 111 antibodies, may have relevance for MAb-based immunodiagnostic assays used to detect p57 in infected salmonids (Hsu et al. 1991 , Rockey et al. 1991a ). Inclusion of individual or combinations of these MAbs would increase the number of epitopes detected and may thereby increase the sensitivity of these ELISAs.
The capture ELISA assay revealed an interesting aspect of the antigenic structure of p57. We observed that when the same MAb was used for both the coating and detection, binding of the biotinylated detection MAb was not observed. This was not due to a failure of the coating antibody to bind p57 because the heterologous biotinylated MAbs and biotinylated rabbit polyclonal antisera each bound well. This result was the same with each of the 3 group I MAbs suggesting that each epitope was functionally available only once per molecule of p57. These data are consistent with a monomer structure of p57. A dimer or aggregate of p57, containing 2 or more copies of the same epitope, would allow the simultaneous binding of both the homologous coating and detecting antibody, providing that the epitopes are not masked by dimerization or aggregation. Our failure to detect binding when homologous MAbs were used was not due to an inability to detect aggregates of p57 as 4D3 and biotinylated 4D3 were able to bind formalin-fixed Renibacteriurn salmoninarum cells that contain multiple copies of p57. The absence of repeated epitopes was surprising as Barton et al. (1997) have recently reported aggregation of p57 occurred after separation by SDS-PAGE and elution with SDS and Triton X-100. In addition, we have observed MAb immunoreactive bands much larger than 57 kDa in ECP preparations resolved under reducing SDS-PAGE conditions (Wiens & Kaattari 1991) . It is possible that the capture ELISA assay was unable to detect small amounts of p57 aggregates in ECP, or perhaps denaturing conditions are necessary for aggregation. P57 has been described to form short, flexible, < 2 nm diameter fimbriae that extend beyond the polysaccharide capsule (Dubreuil et al. 1990a,b) . Presently, the relationship between fimbrae, cell associated p57, and the secreted p57 in ECP is unclear. The monomers in ECP may result from proteolysis or unfolding of a dimer or multimer on the bacterial cell surface.
To independently determine the native molecular weight of p57 in the absence of apparent denaturation, p57 was purified from ECP using ion-exchange and size exclusion chromatography. P57 was partially purified and eluted with a M, of 46 500 consistent with a monomeric structure. The estimated relative molecular mass was smaller than the molecular mass of 54 505 Da calculated from the amino acid sequence of the mature protein (Chien et al. 1992) . The reason for this discrepancy is unknown. A small amount of p45 breakdown product was present (Fig. 6, lane 3) , however, the majority of p57 in our analysis appears identical to p57 in unfractionated ECP by Western blot, suggesting that difference in migration was not due to extensive proteolysis during purification. Possibly p57 exhibits a compact structure under nondenaturing conditions. Secondary amino acid structure prediction supports this possibility as p57 is composed of predominatly beta-regions with little alpha-helix (unpubl. data).
Since a number of agglutinins are multimeric structures, yet p57 eluted as a monomer, the biological activity was tested in both haemagglutination and leucoagglutination assays. In vitro addition of the partially purified p57 monomer to rainbow trout leucocytes and rabbit erythrocytes was sufficient to cause agglutination and the activity was increased 2-fold by purification. The small increase in biological activity after purification was not unexpected as p57 is the major component of Renihactenum salmoninarum ECP (Getchell et al. 1985 , Wiens & Kaattari 1991 , Barton et al. 1997 ). The agglutinating activity was specific to p57 as it was blocked by MAb 4H8. Interestingly, capture ELISA analysis suggested that a monomer was also the predominant from of p57 in kidney homogenates from 3 naturally-infected adult chinook salmon. From these data we propose a model of p57 in which, at least initially, a monomer is sufficient to initiate agglutinating activity and is released by R. salmoninarum during in vivo infection.
Assuming that p57 agglutinates cells in a receptorspecific manner, we propose 3 potential mechanisms of p57 monomer-mediated agglutination. In the first mechainsm, p57 may initially be a monomer but may dimerize or aggregate after binding to a eucaryotic cell receptor. The binding site on p57 is likely located on the amino-terminal portion of p57 as MAbs that block agglutination bind this region. Once initial binding to the leucocyte occurs, the carboxy-region could be exposed. The exposed portions of p57 on adjacent leucocytes or erythrocytes might then dimerize or multimerize resulting in agglutination. While there is no direct evidence of the carboxy-region facilitating aggregation, p57 can aggregate after exposure to denaturing conditions (Barton et al. 1997) . In, addition, secreted p57 is capable of reassembly onto the Renibacterium salmoninarum cell surface (Daly & Stevenson 1990 , Piganelli et al. 1999a ). The carboxy-terminal portion has been implicated in attachment to the bacterial cell surface as partial proteolysis of p57 leaves carboxy-terminal fragments but not amino-terminal fragments associated with the bacterium (Wiens & Kaattari 1991) .
A second possible mechanism of monomer-mediated agglutination may be via proteolysis of host cell surface receptors. Haemagglutinins from both Vibrio cholerae and Pseudornonas aeruginosa have zinc/calcium dependent proteolytic activity that is able to modify erythrocyte surfaces and thereby induce agglutination (Hase & Finkelstein 1990) . This mechanism requires p57 to posess proteolytic activity. Lynch and collegues have demonstrated that p57, and several lower molecular weight products of p57, continue to degrade during 2-dimensional electrophoretic separation of ECP (Gnffiths & Lynch 1991 , Barton et al. 1997 ). Furthermore, p57, and degradation products of p57 isolated from the WC strain of Renibacterium salrnoninarum, comigrate with PMSF-sensitive proteolytic activity detected by gelatin substrate gels. Taken together these results suggests that p57 is autoproteolytic (Barton et al. 1997) . Sequence analysis of p57 is consistent with this possibility as there is homology between the second repeated region of p57 and both trypsin-like and V8 staphylococcal-type serine proteases (Chien et al. 1992 ). In addition, a consensus serine protease motif G-X-S-X-G has been located from Gly-406 and Gly-4 10 between repeats B2 and B3 ( Fig. 2A) (Grayson et al. 1995) . We however have previously failed to detect autoproteolytic activity of p57 purified by isoelectric focusing from the ATCC 33209 and D6 strains (Rockey et al. 1991b ), though as Barton et al. (1997) point out, this could be due to inactivation of proteolytic activity during isoelectric focusing. While we did not initially design these experiments to investigate the autoproteolytic activity of p57, our main finding was that agglutinating activity did not elute with azoalbumin proteolytic activity suggesting that the azoalbumin proteolytic activity is a distinct molecule from p57. In addition, the agglutinating activity of ECP was not inhibited by PMSF or EDTA suggesting that neither serine nor divalent cation dependent proteolytic activity is required for agglutination (G. D. Wiens unpubl. data). The presence of a protease in ECP separate from p57 is consistent with our previous observations that ECP incubated at 37°C contains a molecule of >l00 kDa that is PMSF-sensitive with proteolytic activity but no detectable p57 (Rockey et al. 1991 ). In addition, the n~o l e c u l e having proteinase activity h a d a n isoelectric point between 6.5 a n d 7.5 which is distinct from t h e 4.5 isoelectric point of p57 (Rockey e t al. 1991) . In summary, our d a t a a r g u e against a protease dependent model of agglutination, though the role of the G-X-S-X-G serine protease motif in agglutination remains to b e formally tested by sitedirected mutagenesis.
A third mechanism whereby p57 agglutinates cells m a y b e via t h e recognition a n d cross-linking of differe n t cellular receptors. It is possible that 2 separate agglutinating domains exist, e a c h specific for a separate receptor. Results from t h e antigen capture ELISA provides potential evidence for this model a s MAbs 4 C l l a n d 4H8, which a r e able to inhibit leucoagglutinating activity, bind to separate epitopes. Superantigens, many which a r e produced by Gram-positive bacteria, have such bifunctional properties a n d a r e able to bind a n d crosslink both major histocompatibility class I1 molecules a n d T cell receptors (Seth e t al. 1994) . P57 is unlike other superantigens from Gram-positive bacteria as, to our knowledge, superantigens from Grampositive bacteria d o not agglutinate erythrocytes (Johnson e t al. 1991) . Support for this mechanism awaits analysis of t h e mitogenic activity of purified p57 a n d the identification of t h e leucocyte surface receptor(s).
In summary, w e demonstrate that agglutination-neutralizing group I MAbs recognize separate epitopes on t h e amino-terminal portion of p57 a n d that a monomer is t h e predominant subunit structure of p57 in E C P a n d in infected fish tissue. T h e role of t h e monmeric p57 in pathogensis is unclear. O n e cellular target of p57 may b e salmonid leukocytes where it may down regulate immune function of t h e salmonid host leading to a nonproductive response. In support of this possibility, p57 inhibits specific antibody production in vitro (Turaga e t al. 1987a , Rockey et al. 1991b , a n d Wiens & Kaattari 1991, Fredriksen e t al. 1997) a n d injection of p57 into coho salmon eggs results in long term immunosuppression (Brown e t al. 1996) . T h e presence of bacterial cell-associated p57 is also likely to b e critical in pathogensis a s the creation of p57-cells by the activation of a n endogenous PMSF-senstive protease leads to a n increased humoral response toward carbohydrate moieties on t h e bacterial cell surface (Wood & Kaattari 1996 , Piganelli e t al. 1999a ). In addition, results from preliminary vaccine trials using 37°C treated Renibacterium salmoninarum cells suggest that t h e removal of p57 is critical for t h e induction of protective immunity in salmonids (Piganelli e t al. 1999b) . T h e future analysis of p57 mutants should facilitate t h e characterization of functional domain(s) a n d may clarify how the presence of p57 impairs t h e development of protective immunity in salmonids.
